Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market
HealthcareServices

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size to Exceed $2.6 Billion by 2029 | Growth and Industry Trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Grown from 2024 to 2025?

The market for endoscopic retrograde cholangiopancreatography (ERCP) has experienced substantial growth recently. It is predicted to increase from $1.72 billion in 2024 to $1.87 billion in 2025 with a compound annual growth rate (CAGR) of 8.87%. The previous growth can be associated with an increase in various chronic gastrointestinal illnesses, expanded use of ERCP, a higher number of pancreatic cancer cases, increased government investment, and the rise of medical tourism.

What Growth Rate Is Anticipated for the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market in the Coming Years?

There is a strong growth projection for the endoscopic retrograde cholangiopancreatography (ERCP) market in the coming years, with its size expected to hit $2.60 billion by 2029, a compound annual growth rate (CAGR) of 8.58%. The growth within this forecast period is due largely to the rising prevalence of gastrointestinal issues, increased cancer cases, augmented focus on funding, growing incidents of pancreatic duct, and amplified demand for endoscopes. Key trends within this period include advancements in technology, collaborative efforts towards research and development, growth of the healthcare infrastructure, increased government healthcare spending, and new product development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

Who Are the Leading Companies in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

Major companies operating in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

What Are the Key Drivers of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

The rise in gastrointestinal conditions is anticipated to fuel the progress of the endoscopic retrograde cholangiopancreatography (ERCP) market in the forthcoming years. Gastrointestinal conditions encompass a wide array of disorders or diseases impacting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, and anus, along with associated organs such as the liver, gallbladder, and pancreas. This upsurge in the prevalence of gastrointestinal conditions is linked to numerous factors like changes in diet, aging population, use of antibiotics, lifestyle modifications, and environmental influences. ERCP serves as a minimally invasive approach to diagnose and treat complications within the bile and pancreatic ducts like gallstones, strictures, tumors, or infections, thereby benefitting patients with gastrointestinal conditions. For example, the American Cancer Society, a non-profit organization based in the US, estimated in January 2024 that approximately 26,890 new stomach cancer cases are present in the United States with around 10,880 expected deaths from this cancer type. Consequently, the escalating prevalence of gastrointestinal conditions is contributing to the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20770&type=smp

What Are the Key Market Segments in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Industry?

The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –

1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett’s Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn’s Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications

3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

What Are the Latest Trends in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

Key players in the ERCP market are prioritizing the creation of novel technologies, like the cholangioscope direct visualisation system, in an effort to offer improved, high-definition direct visualisation of the bile and pancreatic ducts. This medical equipment offers enhanced, high-definition imagery of the bile and pancreatic ducts during ERCP treatments. In July 2024, for example, Penlon Limited, a medical equipment company based in the UK, unveiled the VedVision Cholangioscope Direct Visualisation System, a sophisticated medical instrument engineered for improved, direct visual observation of the bile and pancreatic ducts, thus improving diagnostic procedures and therapeutic interventions during ERCP procedures. It comes equipped with a 2 mm accessory channel and a devoted guidewire channel for secure access, bolstered by a varied selection of accessories like biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

What Are the Key Regional Markets in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Industry?

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20770

This Report Delivers Insight On:

1. How big is the endoscopic retrograde cholangiopancreatography (ercp) market, and how is it changing globally?

2. Who are the major companies in the endoscopic retrograde cholangiopancreatography (ercp) market, and how are they performing?

3. What are the key opportunities and risks in the endoscopic retrograde cholangiopancreatography (ercp) market right now?

4. Which products or customer segments are growing the most in the endoscopic retrograde cholangiopancreatography (ercp) market?

5. What factors are helping or slowing down the growth of the endoscopic retrograde cholangiopancreatography (ercp) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model